Abu Dhabi: Abu Dhabi Islamic Bank (ADIB), a leading financial institution, has led a COVID-19 inoculation programme that has now been taken up by over 900 employees. The opt-in programme, which has been run in coordination with the Abu Dhabi Healthcare Company (SEHA), has been led from ADIB’s Head Office and will be rolled out to the bank’s other key premises across the UAE over the coming weeks with the aim of reaching 50% of the entire workforce.

Abdullah Al Attar, Head of Administration at ADIB, said: “We have made incredible progress in our inoculation programme for employees with more than 900 members of our workforce having now received an initial dose of the vaccine. During the pandemic, the health and safety of our employees and customers has been our main concern. By prioritising the rollout of the vaccine to protect our staff, we’re also supporting the UAE’s wider efforts to inoculate more than half the population by the end of March.”

Throughout the COVID-19 pandemic, ADIB has provided relief measures for customers, including the postponement of monthly installment payments and the reduction of certain fees or charges across a range of products, in line with the Central Bank of the UAE’s Targeted Economic Support Scheme. ADIB has also collaborated with the Abu Dhabi Department of Finance to be part of the SME Credit Guarantee Scheme, which aims to bolster the resilience of SMEs registered and operating in the Emirate by increasing access to finances.

In addition to supporting customers, ADIB has also offered extensive support to the community during the COVID-19 outbreak. Initiatives include donating AED 25 million to the Ma’an’s ‘Together We Are Good’ programme, designed to encourage financial and in-kind contributions from individuals and companies to support the community.

According to Our World In Data, an Oxford University-based research centre, the UAE is ranked second highest in the world for vaccination rates, with over 19.93 doses administrated for every 100 people, and close to 2 million vaccinations have been given to citizens and residents since the rollout commenced in December 2020. The UAE is on track to inoculate over 50% of its population by the end of March 2021.

-Ends-

About ADIB

ADIB is a leading bank in the UAE with more than AED 127 billion in assets. The bank also offers world-class online, mobile and phone banking services, providing clients with seamless digital access to their accounts 24 hours a day. ADIB provides retail, corporate, business, private banking and wealth management solutions. The bank was established in 1997 and its shares are traded on the Abu Dhabi Securities Exchange (ADX).

ADIB has presence in six strategic markets: Egypt, where it has 70 branches, the Kingdom of Saudi Arabia, the United Kingdom, Sudan and Iraq.

Named World’s Best Islamic Bank by The Financial Times’ The Banker publication, ADIB has a rich track record of innovation, including introducing the award-winning Ghina savings account, award-winning co-branded cards with Emirates airlines, Etihad and Etisalat and a wide range of financing products.

For media information, please visit www.adib.ae or contact:
ADIB                                                                      Brunswick Group
Radwa Shehab                                                    Sarah Abdelbary
Head of External Communications                 Account Director
Direct: +971 2 6910169                                     Direct: +971 2 234 4600

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.